Jun 30, 2026 07:30AM
Jun 30, 2026 07:30AM
May 14, 2026 07:00AM
May 13, 2026 07:30AM
May 7, 2026 04:05PM
Apr 17, 2026 04:05PM
Apr 17, 2026 04:05PM Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
Mar 23, 2026 07:00AM
Mar 23, 2026 07:00AM
Feb 3, 2026 06:45AM
Feb 3, 2026 06:45AM
Jan 12, 2026 10:14AM
Dec 18, 2025 07:00AM
Dec 18, 2025 07:00AM Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Nov 3, 2025 07:00AM
Oct 13, 2025 04:05PM
Apr 25, 2025 01:18PM
Apr 25, 2025 01:17PM
Mar 25, 2025 04:30PM
Mar 18, 2025 07:30AM
Feb 26, 2025 07:31AM Pyxis Oncology (PYXS) Granted FDA Fast Track Designation for PYX-201
Feb 26, 2025 07:30AM
Nov 28, 2023 07:11AM
Nov 28, 2023 07:00AM
May 24, 2023 06:45AM
May 24, 2023 06:45AM
May 11, 2023 07:00AM
Mar 22, 2023 06:45AM Pyxis Oncology Reports Financial Results for the Fiscal Year Ended December 31, 2022, and Provides Corporate Update
Dec 1, 2022 07:39AM
Dec 1, 2022 06:45AM
Nov 1, 2022 06:30AM
Aug 15, 2022 07:00AM
Mar 29, 2022 11:01AM
Mar 29, 2022 11:00AM
Feb 7, 2022 07:55AM Axcella Therapeutics (AXLA) Announces Appointment of New CFO
Feb 7, 2022 07:55AM
Nov 2, 2021 07:38AM

325,129 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All